The article refers to results in animals which means it is probably years - maybe a decade - from being approved. Novo’s patent protection expires in 2033 [0] so it could be that the market is not yet worried about a potential competitor that likely won’t get to market before the IP protection runs out.

[0]: https://www.reddie.co.uk/2024/08/30/the-year-of-ozempic-an-i...